Valuation: Clover Corporation Limited

Market Cap 143M 102M 88.26M 83.57M 75.75M 142M 9.79B 993M 382M 4.98B 385M 376M 15.73B P/E 2026 *
15.4x
P/E 2027 * 11.2x
Enterprise Value 141M 101M 86.84M 82.22M 74.53M 140M 9.63B 977M 376M 4.9B 379M 370M 15.48B EV / Sales 2026 *
1.49x
EV / Sales 2027 * 1.17x
Free-Float
76.93%
Yield 2026 *
-
Yield 2027 * -
1 day-4.44%
1 week-9.47%
Current month-6.01%
1 month-9.47%
3 months-0.58%
6 months+11.69%
Current year+8.86%
1 week 0.85
Extreme 0.85
0.95
1 month 0.85
Extreme 0.85
0.98
Current year 0.7
Extreme 0.7
1.16
1 year 0.52
Extreme 0.525
1.16
3 years 0.34
Extreme 0.337
1.16
5 years 0.34
Extreme 0.337
1.8
10 years 0.34
Extreme 0.337
3.31
Manager TitleAgeSince
Chief Executive Officer - 10/11/2014
Director of Finance/CFO - 05/05/2021
Chief Operating Officer - 02/02/2011
Director TitleAgeSince
Director/Board Member - 10/11/2014
Chairman - 20/09/2017
Director/Board Member - 31/01/2017
Date Insider Type Main position Quantity % Market Cap. Importance
18/11/25 Sell

Chief Executive Officer

255,199 0.1528%
18/11/25 Buy

Chief Executive Officer

529,638 0.3171%
06/11/25 Buy

Chief Financial Officer

2,447 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-4.44%-9.47%+63.81%-21.10% 107M
-2.39%-1.30%+5.24%+62.94% 12.13B
-0.54%-3.37%-19.16%+259.58% 8.8B
-1.80%-5.88%-23.35%-51.23% 2.32B
-3.39%-4.55%-17.88%-11.30% 1.43B
+0.09%+0.15%+22.25%+71.96% 1.36B
-2.12%-2.91%+25.73%-17.61% 1.26B
-1.72%-12.03%-75.99%-77.72% 1.06B
-3.46%-12.90%-47.74% - 998M
-3.91%-14.06%-63.74%-71.00% 870M
Average -2.37%-6.39%-13.08%+16.06% 3.03B
Weighted average by Cap. -1.80%-3.97%-9.86%+96.85%

Financials

2026 *2027 *
Net sales 94M 67.42M 58.09M 55M 49.85M 93.53M 6.44B 653M 251M 3.28B 253M 248M 10.35B 116M 83.27M 71.74M 67.93M 61.57M 116M 7.96B 807M 310M 4.05B 313M 306M 12.79B
Net income 9.8M 7.03M 6.06M 5.73M 5.2M 9.75M 671M 68.1M 26.19M 342M 26.4M 25.82M 1.08B 13.5M 9.68M 8.34M 7.9M 7.16M 13.43M 925M 93.82M 36.08M 471M 36.36M 35.56M 1.49B
Net Debt -2.3M -1.65M -1.42M -1.35M -1.22M -2.29M -158M -15.98M -6.15M -80.18M -6.2M -6.06M -253M -7.2M -5.16M -4.45M -4.21M -3.82M -7.16M -493M -50.03M -19.24M -251M -19.39M -18.97M -793M
Logo Clover Corporation Limited
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Employees
68
Date Price Change Volume
14/09/26 A$0.8600 -4.44% 22,890
11/09/26 A$0.9000 -4.26% 33,165
10/09/26 A$0.9400 +1.08% 72,074
09/09/26 A$0.9300 -2.11% 47,283
08/09/26 A$0.9500 0.00% 78,912
Trader
-
Investor
Global
-
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.9000AUD
Average target price
1.280AUD
Spread / Average Target
+42.22%

Annual profits - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!